08:06 AM EDT, 08/18/2025 (MT Newswires) -- Theratechnologies ( THTX ) Monday encouraged shareholders to vote in favor of its proposed acquisition by CB Biotechnology, an affiliate of Future Pak, at a special meeting on Friday.

The company said the deal offers $3.01 per share in cash plus up to $1.19 per share through contingent value rights, tied to future product milestones, representing a 216% premium over the stock's price prior to the initial proposal in April 2025.

Theratechnologies ( THTX ) said its board and special committee unanimously supported the deal, calling it fair and in the best interests of shareholders.

Major shareholder Soleus Capital, which owns a 10.4% stake, and senior officers and directors have agreed to vote in favor of the transaction, the company said.